268 related articles for article (PubMed ID: 33247391)
41. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.
Lin JH
Clin Pharmacokinet; 1991 Mar; 20(3):218-36. PubMed ID: 1673880
[TBL] [Abstract][Full Text] [Related]
42. Clinical importance of the new H2-antagonists.
Walt RP
Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():97-9. PubMed ID: 2566730
[TBL] [Abstract][Full Text] [Related]
43. Ranitidine and nizatidine stimulate antral smooth muscle contractility via excitatory cholinergic mechanisms.
Parkman HP; Pagano AP; Ryan JP
Dig Dis Sci; 1998 Mar; 43(3):497-505. PubMed ID: 9539643
[TBL] [Abstract][Full Text] [Related]
44. [Nizatidine: a meta-analytical study].
di Ciommo V; Ferrario F
Clin Ter; 1993 Sep; 143(3):201-7. PubMed ID: 8222550
[TBL] [Abstract][Full Text] [Related]
45. Susceptibility of the H2-receptor antagonists cimetidine, famotidine and nizatidine, to metabolism by the gastrointestinal microflora.
Basit AW; Newton JM; Lacey LF
Int J Pharm; 2002 Apr; 237(1-2):23-33. PubMed ID: 11955801
[TBL] [Abstract][Full Text] [Related]
46. Exposure to Ranitidine and Risk of Bladder Cancer: A Nested Case-Control Study.
Cardwell CR; McDowell RD; Hughes CM; Hicks B; Murchie P
Am J Gastroenterol; 2021 Aug; 116(8):1612-1619. PubMed ID: 34028367
[TBL] [Abstract][Full Text] [Related]
47. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
Savarino V
Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
[TBL] [Abstract][Full Text] [Related]
48. Simultaneous determination of cimetidine, famotidine, nizatidine, and ranitidine in tablets by capillary zone electrophoresis.
Wu SM; Ho YH; Wu HL; Chen SH; Ko HS
Electrophoresis; 2001 Aug; 22(13):2758-62. PubMed ID: 11545404
[TBL] [Abstract][Full Text] [Related]
49. A comparison of the cholinergic activity of selected H2-antagonists and sulfoxide metabolites.
Kosh JW; Sowell JW; Chapman JM
Pharm Res; 1989 Aug; 6(8):709-13. PubMed ID: 2573049
[TBL] [Abstract][Full Text] [Related]
50. Nocturnal doses of ranitidine and nizatidine do not affect the disposition of diazepam.
Klotz U; Gottlieb W; Keohane PP; Dammann HG
J Clin Pharmacol; 1987 Mar; 27(3):210-2. PubMed ID: 2890666
[TBL] [Abstract][Full Text] [Related]
51. Safety of nizatidine in clinical trials conducted in the USA and Europe.
Cloud ML
Scand J Gastroenterol Suppl; 1987; 136():29-36. PubMed ID: 2892253
[TBL] [Abstract][Full Text] [Related]
52. Twenty-four-hour control of gastric acidity by twice-daily doses of placebo, nizatidine 150 mg, nizatidine 300 mg, and ranitidine 300 mg.
Savarino V; Mela GS; Zentilin P; Cutela P; Mele R; Celle G
J Clin Pharmacol; 1993 Jan; 33(1):70-4. PubMed ID: 8429117
[TBL] [Abstract][Full Text] [Related]
53. H2-antagonists and alcohol. Do they interact?
Gugler R
Drug Saf; 1994 Apr; 10(4):271-80. PubMed ID: 7912509
[TBL] [Abstract][Full Text] [Related]
54. Nizatidine, an H2-blocker. Its metabolism and disposition in man.
Knadler MP; Bergstrom RF; Callaghan JT; Rubin A
Drug Metab Dispos; 1986; 14(2):175-82. PubMed ID: 2870891
[TBL] [Abstract][Full Text] [Related]
55. The effect of an oral morning dose of nizatidine and ranitidine on gastric acid secretion in duodenal ulcer patients.
Lazzaroni M; Bianchi Porro G
Hepatogastroenterology; 1989 Dec; 36(6):490-3. PubMed ID: 2575571
[TBL] [Abstract][Full Text] [Related]
56. Pharmacology of H2-receptor antagonists: an overview.
Schunack W
J Int Med Res; 1989; 17 Suppl 1():9A-16A. PubMed ID: 2566544
[TBL] [Abstract][Full Text] [Related]
57. [Nizatidine versus ranitidine in the treatment of acute duodenal ulcer. Comparison of 300 mg nizatidine and 300 mg ranitidine in a single evening dose].
Arnold R; Beckenbach P; Bock H; Bormann R; Daake H; Dammann HG; Du Bosque G; Fürer M; Geiter B; Hebbeln H
Fortschr Med; 1989 Jul; 107(21):467-70. PubMed ID: 2570012
[TBL] [Abstract][Full Text] [Related]
58. Anti-oxidant properties of H2-receptor antagonists. Effects on myeloperoxidase-catalysed reactions and hydroxyl radical generation in a ferrous-hydrogen peroxide system.
van Zyl JM; Kriegler A; van der Walt BJ
Biochem Pharmacol; 1993 Jun; 45(12):2389-97. PubMed ID: 8101078
[TBL] [Abstract][Full Text] [Related]
59. An antibody from a patient with ranitidine-induced thrombocytopenia recognizes a site on glycoprotein IX that is a favored target for drug-induced antibodies.
Gentilini G; Curtis BR; Aster RH
Blood; 1998 Oct; 92(7):2359-65. PubMed ID: 9746775
[TBL] [Abstract][Full Text] [Related]
60. Histamine-2 receptor antagonists and gastric cancer.
Johnson AG; Jick SS; Perera DR; Jick H
Epidemiology; 1996 Jul; 7(4):434-6. PubMed ID: 8793372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
